Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening

References

• Hakama M, Miller AB, Day NE, (eds.). Screening for cancer of the uterine cervix. Lyon, France: International Agency for Research on Cancer, 1986; IARC Sci. Pub. No.76.
   Google Scholar
• del Moral Aldaz A, Aupee M, Batal-Steil S, Cecchini S, Chamberlain J, Ciatto S et al. Cancer screening in the European Union. A Workshop Report. Eur J Cancer 1994; 30A: 860–86.
   PubMedGoogle Scholar
• Bjørge T, Thoresen SØ, Gunbjørud AB. Masseundersokelsen mot livmorhalskreft. Nå starter invitasjonene av kvinner på landsbasis.(Mass screening for cervical cancer. Nationwide invitations of women start now.) Tidsskr Nor Laege-foren 1995; 115: 815–16. (In Norwegian)
   Google Scholar
• Magnus K, Langmark F, Andersen A. Mass screening for cervical cancer in Østfold county of Norway 1959–77. Int J Cancer 1987; 39: 311–16.
   Google Scholar
• Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: Association with organized screening programmes. Lancet 1987; 1: 1247–9.
   Google Scholar
• Boyle P, Veronesi U, Tubiana M, Alexander FE, Calais da Silva F, Denis LJ et al. European School of Oncology Advisory Report to the European Commission for the ‘Europe against Cancer Programme’ European Code Against Cancer. Eur J Cancer 1995; 1A: 1395–405.
   Google Scholar
• Gustafsson L, Sparen P, Gustafsson M, Wilander E, Bergstrøm R, Adami HO. Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix. Br J Cancer 1995; 72: 498–505.
   Google Scholar
• Bjørge T, Gunbjørud AB, Haugen OA, Skare GB, Trope C, Thoresen SØ. Mass screening for cervical cancer in Norway: evaluation of the pilot project. Cancer Causes Control 1995; 6: 477–84.
   PubMed Web of Science ®Google Scholar
• Eide TJ, Engh V, Stalsberg H. Cervixcancer. Redusert insidens og mortalitet i Troms og Finnmark 1973–1984. (Cervical cancer. Reduced incidence and mortality in Troms and Finnmark county 1973–1984) Tidsskr Nor Laegeforen 1987; 107: 1199–203. (In Norwegian)
   Google Scholar
• Gram IT, Macaluso M, Churchill J, Stalsberg H. Trichomonas Vaginalis (TV) and human papillomavirus (HPV) infection and the incidence of cervical intraepithelial neoplasia (CIN) grade III. Cancer Causes Control 1992; 3: 231–6.
   PubMedGoogle Scholar
• Rothman KJ. Modern epidemiology. Boston, MA: Little, Brown & Company, 1986.
   Google Scholar
• Breslow NE, Day NE. Statistical methods in cancer research. Vol. II – The design and analysis of cohort studies. Lyon: France. International Agency for Research on Cancer, Sci. Pub. no. 1987; 82.
   Google Scholar
• Macaluso M. Exact stratification of person-years. Epidemiology 1992; 3: 441–8.
   Google Scholar
• Statistics and epidemiologic research corporation. EGRET User’s Manual. Seattle, Washington, 1989.
   Google Scholar
• SAS INSTITUTE INC. SUGI Supplemental Library user’s guide, 1983 edition. Cary NC, SAS Institute. 1983.
   Google Scholar
• Duguid HLD, Duncan ID, Currie J. Screening for cervical intraepithelial neoplasia in Dundee and Angus 1962–81 and its relation with invasive cervical cancer. Lancet 1985; 2: 1053–6.
   Google Scholar
• Mitchell M, Medley G. Age and time trends in the prevalence of cervical intraepithelial neoplasia on Papanicolaou smear tests, 1970–1988. Med J Aust 1990; 152: 252–5.
   Google Scholar
• Forsmo S, Buhaug H, Stalsberg H. Use of pap-smears in a population without a mass screening program. Acta Obstet Gynecol Scand 1994; 73: 824–8.
   Web of Science ®Google Scholar
• Bjørge T, Gunbjørud AB, Langmark F, Skare GB, Thoresen SØ. Cervical mass screening in Norway – 510,000 smears a year. Cancer Detect Prev 1994; 18: 463–70.
   Google Scholar
• Gram IT, Austin H, Stalsberg H. Cigarette smoking and the incidence of cervical intraepithelial neoplasia, grade III, and cancer of the cervix uteri. Am J Epidemiol 1992; 135: 341–6.
   Google Scholar
• Gram IT, Macaluso M, Stalsberg H. Oral contraceptive use and the incidence of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1992; 167: 40–4.
   Google Scholar
• Soutter WP, de Barros Lopes A, Fletcher A, Monaghan JM, Duncan ID, Paraskevaidis E et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 1997; 349: 978–80.
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Fransceshi S, Decarli A, Fasoli M, Gentile A, Tognoni G. «Pap» smear and the risk of cervical dysplasia: quantitative estimates from a case-control study. Lancet 1984; 2: 779–82.
   Google Scholar
• Jones CJ, Brinton LA, Hamman RF, Stolley PD, Lehman HF, Levine RS, et al. Risk factors for in situ cervical cancer: results from a case-control study. Cancer Res 1990; 50: 3657–62.
   PubMed Web of Science ®Google Scholar
• Forsmo S, Jacobsen BK, Stalsberg H. Cervical neoplasia in pap smears: risk of cervical intra-epithelial neoplasia CIN) after negative or no prior smears in a population without a mass screening programme. Int J Epidemiol 1996; 25: 53–8.
   Google Scholar